KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Goodwill: 2009-2024

Historic Goodwill for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $405.1 million.

  • Idexx Laboratories' Goodwill rose 0.38% to $413.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $413.7 million, marking a year-over-year increase of 0.38%. This contributed to the annual value of $405.1 million for FY2024, which is 10.69% up from last year.
  • As of FY2024, Idexx Laboratories' Goodwill stood at $405.1 million, which was up 10.69% from $366.0 million recorded in FY2023.
  • Idexx Laboratories' Goodwill's 5-year high stood at $405.1 million during FY2024, with a 5-year trough of $243.3 million in FY2020.
  • Its 3-year average for Goodwill is $377.6 million, with a median of $366.0 million in 2023.
  • Data for Idexx Laboratories' Goodwill shows a peak YoY skyrocketed of 47.67% (in 2021) over the last 5 years.
  • Idexx Laboratories' Goodwill (Yearly) stood at $243.3 million in 2020, then skyrocketed by 47.67% to $359.3 million in 2021, then grew by 0.68% to $361.8 million in 2022, then rose by 1.15% to $366.0 million in 2023, then rose by 10.69% to $405.1 million in 2024.